[Reducing of hepatotoxicity of antineoplastic chemotherapy and concomitant viral infection through control of liver metabolism: from experiment to clinical practice].
Bogush
T A
TA
Bogush
E A
EA
Durnov
L A
LA
Syrkin
A B
AB
D000328:Adult; D000367:Age Factors; D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000633:toxicity; D001219:Aspartate Aminotransferases / Q000097:blood; D001559:Benzhydryl Compounds / Q000494:pharmacology; D002648:Child; D003577:Cytochrome P-450 Enzyme System / Q000187:drug effects / Q000378:metabolism; D004790:Enzyme Induction / Q000187:drug effects; D005260:Female; D006801:Humans; D008099:Liver / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism*; D008297:Male; D051379:Mice; D008875:Middle Aged; D011247:Pregnancy; D012737:Sex Factors; D013997:Time Factors; D014777:Virus Diseases / Q000150:complications*
D000970:Antineoplastic Agents; D001559:Benzhydryl Compounds; D003577:Cytochrome P-450 Enzyme System; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; C016914:flumecinol